News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Medicilon-MPI Preclinical Research (Shanghai) LLC Celebrates its Grand Opening


10/17/2008 10:02:21 AM

SHANGHAI, China--(BUSINESS WIRE)--Medicilon/MPI Preclinical Research-Shanghai is pleased to announce the Grand Opening of its new preclinical research facility. The two parent companies, Shanghai Medicilon and MPI Research, are equally represented in this new joint venture. The 50,000 square foot building is located in the Chuansha Economic Park in Shanghai, China. This new facility will meet the regulatory standards set forth by the US FDA and other regulatory agencies worldwide.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES